How should baclofen and a proton‑pump inhibitor be dosed to treat hiccups persisting longer than 48 hours?

Treatment of Hiccups Persisting Over 48 Hours with Baclofen and PPI

For hiccups lasting longer than 48 hours, initiate baclofen 5 mg three times daily and titrate up by 5 mg every 3-4 days to a maintenance dose of 20 mg three times daily, combined with standard-dose PPI therapy (e.g., omeprazole 20-40 mg daily). 1, 2

Rationale for Combined Therapy

Why Start with PPI

• GERD is the most common underlying cause of persistent hiccups, making empiric PPI therapy a logical first-line approach even before confirming reflux disease 3
• Standard single-dose PPI therapy should be initiated for 4-8 weeks as per AGA guidelines for suspected GERD-related symptoms 4
• If inadequate response occurs, PPI dosing can be increased to twice daily 4

Why Add Baclofen

• Baclofen is supported by the highest quality evidence among hiccup treatments, including randomized placebo-controlled trials, whereas most other agents rely only on case reports 1, 5
• Baclofen specifically reduces transient lower esophageal sphincter relaxations (TLOSRs), which can trigger both reflux and hiccups through vagal stimulation 2
• The combination addresses both acid reflux and the neurological reflex arc responsible for hiccups 1, 6

Specific Dosing Protocol

Baclofen Titration Schedule

• Start: 5 mg orally three times daily 2, 7
• Titrate: Increase by 5 mg every 3-4 days 2
• Target maintenance: 20 mg three times daily 2
• Expected response time: 48 hours to 1 week 7, 8
• Duration: Continue for at least 1 week after hiccup resolution, then consider tapering 7

PPI Dosing

• Standard dose: Single daily PPI (e.g., omeprazole 20-40 mg, lansoprazole 30 mg, or esomeprazole 40 mg) 4
• If inadequate response: Increase to twice daily dosing 4
• Duration: 4-8 week trial initially 4

Important Safety Considerations

Baclofen Precautions

• CNS depression is the primary concern: Warn patients about sedation, drowsiness, and avoid alcohol or other CNS depressants 9
• Caution in epilepsy: Monitor seizure control as baclofen may worsen seizures 9
• Common side effects: Mild nausea or drowsiness reported in approximately 25% of patients 2
• Not FDA-approved for hiccups: Baclofen is only FDA-approved for spasticity from multiple sclerosis and spinal cord conditions, making this off-label use 9

When This Approach May Fail

• If hiccups persist despite combined therapy, consider:
  • Central nervous system pathology (stroke, tumor, infection) requiring neuroimaging 7, 6
  • Metabolic causes (uremia, electrolyte disturbances) 6
  • Medication-induced hiccups requiring drug discontinuation 6
  • Phrenic nerve irritation from thoracic or mediastinal pathology 6

Alternative Agents if First-Line Fails

Second-Line Options

• Gabapentin: Also supported by small randomized trials, may be preferred if baclofen causes excessive sedation 1, 5
• Metoclopramide: Has randomized trial data but carries risk of tardive dyskinesia with prolonged use 1, 5
• Chlorpromazine: The only FDA-approved agent for hiccups, but higher side effect profile limits long-term use 1, 6

Clinical Pearls

• Baclofen and gabapentin are preferred for long-term therapy over neuroleptics due to superior safety profiles 1
• The combination of PPI and baclofen is particularly effective when hiccups are related to GERD with persistent non-acid reflux 2
• Response to baclofen typically occurs within 48 hours; if no improvement by 1 week at maximum dose, reconsider the diagnosis 7, 8
• Do not abruptly discontinue baclofen after prolonged use due to risk of withdrawal symptoms 9